Reproducibility of Barrett's esophagus histopathologic diagnosis in the presence of focal intestinal metaplasia in endoscopic biopsies;Reprodutibilidade no diagnóstico histopatológico do esôfago de Barrett na presença de metaplasia intestinal focal em biópsias endoscópicas

GED - Gastrenterologia Endoscopia Digestiva

Volumn 23, Issue 2, 2004, Pages 47-52

  Lopes, César Vivian ^a,b   Pereira Lima, Júlio ^a   Hartmann, Antônio Atalíbio ^a   Tonelotto, Eunice ^a  

^a UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^b NONE   (Brazil)

Author keywords

Barrett's esophagus; Intestinal metaplasia; Reproducibility

Indexed keywords

ALCIAN BLUE; BIOTIN; EOSIN; HEMATOXYLIN; MUCIN 2; PEROXIDASE; STREPTAVIDIN;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; ENDOSCOPIC BIOPSY; FEMALE; GOBLET CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; REPRODUCIBILITY; SQUAMOUS EPITHELIUM;

EID: 4644302052     PISSN: 01017772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. DeMeester SR, DeMeester TR. Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. Ann Surg 2000; 231: 303-21.
2. Geboes K, Van Eyken P. The diagnosis of dysplasia and malignancy in Barrett's oesophagus. Histopathology 2000; 37: 99-107.
3. Castell DO, Katzka DA. Barrett's esophagus: continuing questions and controversy. Gastrointest Endosc 1999; 49: S5-S8.
4. Cameron AJ. Epidemiology of columnar-lined esophagus and adenocarcinoma. Gastroenterol Clin North Am 1997; 26: 487-94.
5. Sampliner RE, and The Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002; 97: 1888-95.
6. Morales TG, Sampliner RE. Barrett's esophagus: update on screening, surveillance, and treatment. Arch Intern Med 1999; 159: 1411-6.
7. Rajan E, Burgart LJ, Gostout CJ. Endoscopic and histologic diagnosis of Barrett esophagus. Mayo Clin Proc 2001; 76: 217-25.
8. Canto MI. Vital staining and Barrett's esophagus. Gastrointest Endosc 1999; 49: S12-S16.
9. Chen YY, Wang HH, Antonioli DA, Spechler SJ, Zeroogian JM, Goyal R, et al. Significance of acid-mucin-positive nongoblet columnar cells in the distal esophagus and gastroesophageal junction. Hum Pathol 1999; 30: 1488-95.
10. Nandurkar S, Talley NJ, Martin CJ, Adams S. Short segment Barrett's oesophagus: prevalence, diagnosis and associations. Gut 1997; 40: 710-5.
11. Arul GS, Moorghen M, Myerscough N, Alderson DA, Spicer RD, Corfield AP. Mucin gene expression in Barrett's oesophagus: an in situ hybridization and immunohistochemical study. Gut 2000; 47: 753-61.
12. Namiot Z, Sarosiek J, Marcinkiewicz M, Edmunds MC, McCallum RW. Declined human esophageal mucin secretion in patients with severe reflux disease. Dig Dis Sci 1994; 39: 2523-9.
13. Mighell AJ, Hume WJ, Robinson PA. An overview of the complexities and subtleties of immunohistochemistry. Oral Diseases 1998; 4: 217-23.
14. Montgomery E, Bronner MP, Goldblum JR, Greenson JK, Haber MM, Hart J, et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol 2001; 32: 368-78.
15. Riddell RH. The biopsy diagnosis of gastroesophageal reflux disease, carditis, and Barrett's esophagus, and sequelae of therapy. Am J Surg Pathol 1996; 20: S31-S51.
16. Jacobs TW, Prioleau JE, Stillman IE, Schnitt SJ. Loss of tumour marker-immunostaining intensity on stored paraffin slides of breast cancer. J Natl Cancer Inst 1996; 7: 1054-9.
17. Shi SR, Cote RJ, Taylor CR. Antigen retrieval immunohistochemistry: past, present, and future. J Histochem Cytochem 1997; 45: 327-43.
18. rd ed. New York: Lange Medical Books/McGraw-Hill, 2001.
19. Chandrasoma PT, Der R, Dalton P, Kobayashi G, Ma Y, Peters JH, et al. Distribution and significance of epithelial types in columnar-lined esophagus. Am J Surg Pathol 2001; 25: 1188-93.
20. Kim SL, Waring JP, Spechler SJ, Sampliner RE, Doos WG, Krol WF, et al. Diagnostic inconsistencies in Barrett's esophagus. Gastroenterology 1994; 107: 945-9.
21. Chaves P, Cardoso P, De Almeida JC, Pereira AD, Leitao CN, Soares J. Non-goblet cell population of Barrett's esophagus: an immunohistochemical demonstration of intestinal differentiation. Hum Pathol 1999; 30: 1291-5.
22. Offner FA, Lewin KJ, Weinstein WM. Metaplastic columnar cells in Barrett's esophagus: a common and neglected cell type. Hum Pathol 1996; 27: 885-9.
23. Weinstein WM, Ippoliti AF. The diagnosis of Barrett's esophagus: goblets, goblets, goblets. Gastrointest Endosc 1996; 44: 91-6.
24. Ormsby AH, Kilgore SP, Goldblum JR, Richter JE, Rice TW, Gramlich TL. The location and frequency of intestinal metaplasia at the esophagogastric junction in 223 consecutive autopsies: implications for patient treatment and preventive strategies in Barrett's esophagus. Mod Pathol 2000; 13: 614-20.
25. Lopes CV. Expressão imunoistoquímica da Mucina-2 e da p53 no esôfago de Barrett, no epitélio escamoso adjacente ao metaplásico e na mucosa escamosa gerada após a ablação endoscópica do esôfago de Barrett por eletrocoagulação com argônio [Tese de Doutorado]. Curso de Pós-Graduação em Medicina: Patologia da FFFCMPA. Porto Alegre, 2003.
26. Chinyama CN, Marshall REK, Owen WJ, Mason RC, Kothad D, Wilkinson ML, et al. Expression of MUC1 and MUC2 mucin gene products in Barrett's metaplasia, dysplasia and adenocarcinoma: an immunopathological study with clinical correlation. Histopathology 1999; 35: 517-24.